Economic evaluation
Cost-effectiveness and cost-utility analyses with explicit comparators, perspective and time horizons.
HEALTH ECONOMICS · DECISION SCIENCE
Make health investment decisions explicit, testable and informed by evidence.
We develop economic evaluations and decision frameworks that connect clinical outcomes, costs and uncertainty. Models support transparent deliberation rather than replace clinical or policy judgment.
OUR SCIENTIFIC AGENDA
Cost-effectiveness and cost-utility analyses with explicit comparators, perspective and time horizons.
Frameworks for willingness-to-pay calibration and net monetary benefit across settings.
Probabilistic analysis, ICER stability and NMB/INMB to examine decision robustness.
Protocols, participating institutions, roles, data rights, IP and economic arrangements are documented for each project and may require negotiation with investigators and stakeholders.
Review the scientific collaboration framework →EVIDENCE & OUTPUTS
This methodological study evaluates the empirical stability of the incremental cost-effectiveness ratio relative to net monetary benefit under probabilistic uncertainty, examining which metric communicates decision uncertainty more reliably.
No public preprint or journal article is linked in the verified register.
FOR CLINICIANS & SCIENTIFIC COLLABORATORS
Bring clinical context to economic models: relevant comparators, care pathways, resource use and outcomes that matter to patients.
Define meaningful questions, outcomes and interpretation.
Discuss this contribution →Discuss local service mapping, feasibility and institutional coordination.
Discuss this contribution →Contribute to evidence appraisal, modelling or decision briefs.
Discuss this contribution →WORK WITH THE PROGRAMME
Explore collaboration, project participation and responsible funding through the programme’s existing pathways.
PHILANTHROPY & PARTNERSHIP
Individuals, families, institutions and funders can make a one-time contribution or discuss recurring support. Contributions are separate from membership and preserve scientific independence.
Every new research project, case report, case series or innovation proposal requires written approval from the corresponding Observatory Executive Director or research group principal investigator. Admission or membership does not replace this approval.
If leadership is vacant, microscopIA coordinates proposal intake and review; execution awaits approval from a formally designated scientific authority.
Protocols and collaboration agreementsGOVERNMENTS, INSTITUTIONS & COMMUNITIES
Work with microscopIA on access evaluation, capacity planning, economic analysis, evidence synthesis or programme evaluation. Agree the decision question, methods, data, deliverables and timetable.
Discuss a collaboration →Describe the aim, population and geography, unmet need and proposed Executive Director—you may nominate yourself. Include expertise, methods, expected outputs, partners, resources, funding needs and timeline.
Prepare an email proposal →Jorge Racedo · Managing Director
jorge.racedo@microscopiatech.com
Proposals are evaluated before establishing an initiative, appointment or budget. Send a professional summary without identifiable patient information. Discuss recurring support